During acute rejection, 96% of biopsies had at least some degree/form of glomerulitis.
Glomerulitis is mainly composed of T cells, (IL-17+) neutrophils and macrophages.
None of the quantified cell types appeared to be a good biomarker for the response to antirejection therapy.
Macrophage glomerulitis has a predictive value for graft failure until 500 days after rejection.